Invesaro

Stocks Comparison

Cadre vs Inogen: revenue, profit, margins and growth compared

Cadre brought in $610.3M of revenue in fiscal 2025, Inogen $348.7M in fiscal 2025. Revenue changed by +7.5% at Cadre and +3.9% at Inogen on the year before, so Cadre grew faster. Cadre kept 7.2% of its revenue as net profit, Inogen -6.5%. Free cash flow was $56.8M at Cadre and -$13.7M at Inogen.

Side by side, latest fiscal year

CDREINGN
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$610.3M$348.7M
Revenue growth+7.5%+3.9%
Net income$44.1M-$22.7M
Net margin7.2%-6.5%
Free cash flow$56.8M-$13.7M
Free cash flow margin9.3%-3.9%
Earnings per share (diluted)$1.02-$0.86
Cash$122.9M$103.7M
Debt$307.3Mn/a
Price to earnings25.9n/a
Market value$1.1B$142.2M
Dividend yield0.36%n/a
Rank by revenue in sector#179 of 523 · Health care#213 of 523 · Health care

Over the years

Revenue
CDRE FY2021: $404.6MCDRE FY2021: $427.3MCDRE FY2022: $457.8MCDRE FY2023: $482.5MCDRE FY2024: $567.6MCDRE FY2025: $610.3MINGN FY2018: $358.1MINGN FY2019: $361.9MINGN FY2020: $308.5MINGN FY2021: $358MINGN FY2022: $377.2MINGN FY2023: $315.7MINGN FY2024: $335.7MINGN FY2025: $348.7MFY18FY19FY20FY21FY22FY23FY24FY25
CDRE $610.3MINGN $348.7M
Net income
CDRE FY2021: $38.5MCDRE FY2021: $12.7MCDRE FY2022: $5.8MCDRE FY2023: $38.6MCDRE FY2024: $36.1MCDRE FY2025: $44.1MINGN FY2018: $51.8MINGN FY2019: $21MINGN FY2020: -$5.8MINGN FY2021: -$6.3MINGN FY2022: -$83.8MINGN FY2023: -$102.4MINGN FY2024: -$35.9MINGN FY2025: -$22.7MFY18FY19FY20FY21FY22FY23FY24FY25
CDRE $44.1MINGN -$22.7M
Net margin
CDRE FY2021: 9.5%CDRE FY2021: 3.0%CDRE FY2022: 1.3%CDRE FY2023: 8.0%CDRE FY2024: 6.4%CDRE FY2025: 7.2%INGN FY2018: 14.5%INGN FY2019: 5.8%INGN FY2020: -1.9%INGN FY2021: -1.8%INGN FY2022: -22.2%INGN FY2023: -32.5%INGN FY2024: -10.7%INGN FY2025: -6.5%FY18FY19FY20FY21FY22FY23FY24FY25
CDRE 7.2%INGN -6.5%
Revenue growth
CDRE FY2021: +5.6%CDRE FY2022: +7.1%CDRE FY2023: +5.4%CDRE FY2024: +17.6%CDRE FY2025: +7.5%INGN FY2019: +1.1%INGN FY2020: -14.8%INGN FY2021: +16.1%INGN FY2022: +5.4%INGN FY2023: -16.3%INGN FY2024: +6.4%INGN FY2025: +3.9%FY19FY20FY21FY22FY23FY24FY25
CDRE +7.5%INGN +3.9%
Free cash flow
CDRE FY2021: $40.7MCDRE FY2021: $37.3MCDRE FY2022: $41.9MCDRE FY2023: $66.5MCDRE FY2024: $26.1MCDRE FY2025: $56.8MINGN FY2018: $51.9MINGN FY2019: $37.5MINGN FY2020: $32.6MINGN FY2021: $18.2MINGN FY2022: -$40.9MINGN FY2023: -$8.5MINGN FY2024: $2.6MINGN FY2025: -$13.7MFY18FY19FY20FY21FY22FY23FY24FY25
CDRE $56.8MINGN -$13.7M

Fiscal years as each company reports them; the two may end in different months.

Questions about Cadre and Inogen

Which is bigger by revenue, Cadre or Inogen?

Cadre is bigger by revenue: $610.3M in fiscal 2025, against $348.7M for Inogen in fiscal 2025.

Which keeps more of its revenue as profit, Cadre or Inogen?

Cadre had a net margin of 7.2% in fiscal 2025; Inogen had -6.5% in fiscal 2025.

Which grew revenue faster, Cadre or Inogen?

In their latest fiscal years revenue changed by +7.5% at Cadre and +3.9% at Inogen.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies